A latent class approach for sepsis diagnosis supports use of procalcitonin in the emergency room for diagnosis of severe sepsis

BMC Anesthesiology

Fabián A Jaimes³  Gisela D De La Rosa⁶  Marta L Valencia⁵  Clara M Arango²  Carlos I Gomez²  Alex Garcia⁴  Sigifredo Ospina¹  Susana C Osorno⁵  Adriana I Henao⁵ 

[1] Department of Epidemiology, Hospital Universitario San Vicente de Paul, Medellín, Colombia

[2] Department of Internal Medicine, Hospital Pablo Tobón Uribe, Medellin, Colombia

[3] Grupo Académico de Epidemiología Clínica (GRAEPIC), Universidad de Antioquia, Medellín, Colombia

[4] Intensive Care Unit, Clínica Universitaria Bolivariana, Medellín, Colombia

[5] Department of Internal Medicine, School of Medicine, Universidad de Antioquia, Medellín AA 1226, Colombia

[6] Department of Critical Care, Hospital Pablo Tobón Uribe, Medellín, Colombia

关键词: D-dimer;    Procalcitonin;    C-reactive protein;    Latent class;    Sepsis;    Specificity;    Sensitivity;   

Others  :  816781
DOI  :  10.1186/1471-2253-13-23

 received in 2013-03-12, accepted in 2013-09-12,  发布年份 2013

【 摘 要 】

Background

Given the acknowledged problems in sepsis diagnosis, we use a novel way with the application of the latent class analysis (LCA) to determine the operative characteristics of C-reactive protein (CRP), D-dimer (DD) and Procalcitonin (PCT) as diagnostic tests for sepsis in patients admitted to hospital care with a presumptive infection.

Methods

Cross-sectional study to determine the diagnostic accuracy of three biological markers against the gold standard of clinical definition of sepsis provided by an expert committee, and also against the likelihood of sepsis according to LCA. Patients were recruited in the emergency room within 24 hours of hospitalization and were follow-up daily until discharge.

Results

Among 765 patients, the expert committee classified 505 patients (66%) with sepsis, 112 (15%) with infection but without sepsis and 148 (19%) without infection. The best cut-offs points for CRP, DD, and PCT were 7.8 mg/dl, 1616 ng/ml and 0.3 ng/ml, respectively; but, neither sensitivity nor specificity reach 70% for any biomarker. The LCA analysis with the same three tests identified a “cluster” of 187 patients with several characteristics suggesting a more severe condition as well as better microbiological confirmation. Assuming this subset of patients as the new prevalence of sepsis, the ROC curve analysis identified new cut-off points for the tests and suggesting a better discriminatory ability for PCT with a value of 2 ng/ml.

Conclusions

Under a “classical” definition of sepsis three typical biomarkers (CRP, PCT and DD) are not capable enough to differentiate septic from non-septic patients in the ER. However, a higher level of PCT discriminates a selected group of patients with severe sepsis.

【 授权许可】

   
2013 Jaimes et al.; licensee BioMed Central Ltd.

【 图 表 】

Figure 1.

【 参考文献 】

• [1]Esper AM, Martin GS: Extending international sepsis epidemiology: the impact of organ dysfunction. Crit Care 2009, 13(1):120. BioMed Central Full Text
• [2]Rodriguez F, Barrera L, De La Rosa G, Dennis R, Duenas C, Granados M, Londono D, Molina F, Ortiz G, Jaimes F: The epidemiology of sepsis in Colombia: a prospective multicenter cohort study in ten university hospitals. Crit Care Med 2011, 39(7):1675-1682.
• [3]Slade E, Tamber PS, Vincent JL: The Surviving Sepsis Campaign: raising awareness to reduce mortality. Crit Care 2003, 7(1):1-2. BioMed Central Full Text
• [4]Dellinger RP, Carlet JM, Masur H, Gerlach H, Calandra T, Cohen J, Gea-Banacloche J, Keh D, Marshall JC, Parker MM, et al.: Surviving Sepsis Campaign guidelines for management of severe sepsis and septic shock. Intensive Care Med 2004, 30(4):536-555.
• [5]Levy MM, Dellinger RP, Townsend SR, Linde-Zwirble WT, Marshall JC, Bion J, Schorr C, Artigas A, Ramsay G, Beale R, et al.: The Surviving Sepsis Campaign: results of an international guideline-based performance improvement program targeting severe sepsis. Crit Care Med 2010, 38(2):367-374.
• [6]Rindskopf D, Rindskopf W: The value of latent class analysis in medical diagnosis. Stat Med 1986, 5(1):21-27.
• [7]Garrett ES, Zeger SL: Latent class model diagnosis. Biometrics 2000, 56(4):1055-1067.
• [8]Nielsen LR, Toft N, Ersboll AK: Evaluation of an indirect serum ELISA and a bacteriological faecal culture test for diagnosis of Salmonella serotype Dublin in cattle using latent class models. J Appl Microbiol 2004, 96(2):311-319.
• [9]Limmathurotsakul D, Jamsen K, Arayawichanont A, Simpson JA, White LJ, Lee SJ, Wuthiekanun V, Chantratita N, Cheng A, Day NP, et al.: Defining the true sensitivity of culture for the diagnosis of melioidosis using Bayesian latent class models. PloS one 2010, 5(8):e12485.
• [10]Tuyisenge L, Ndimubanzi CP, Ndayisaba G, Muganga N, Menten J, Boelaert M, Van den Ende J: Evaluation of latent class analysis and decision thresholds to guide the diagnosis of pediatric tuberculosis in a Rwandan reference hospital. Pediatr Infect Dis J 2010, 29(2):e11-e18.
• [11]Matope G, Muma JB, Toft N, Gori E, Lund A, Nielsen K, Skjerve E: Evaluation of sensitivity and specificity of RBT, c-ELISA and fluorescence polarisation assay for diagnosis of brucellosis in cattle using latent class analysis. Vet Immunol Immunopathol 2011, 141(1–2):58-63.
• [12]Claus RA, Otto GP, Deigner HP, Bauer M: Approaching clinical reality: markers for monitoring systemic inflammation and sepsis. Curr Mol Med 2010, 10(2):227-235.
• [13]Tsalik EL, Woods CW: Sepsis redefined: the search for surrogate markers. Int J Antimicrob Agents 2009, 34(Suppl 4):S16-S20.
• [14]Jaimes F, de la Rosa G: Anticoagulation and sepsis: the opportunity for a new use of heparin? Biomedica : revista del Instituto Nacional de Salud 2006, 26(1):150-160.
• [15]Hermans MA, Leffers P, Jansen LM, Keulemans YC, Stassen PM: The value of the Mortality in Emergency Department Sepsis (MEDS) score, C reactive protein and lactate in predicting 28-day mortality of sepsis in a Dutch emergency department. Emerg Med J 2012, 29(4):295-300.
• [16]Uusitalo-Seppala R, Koskinen P, Leino A, Peuravuori H, Vahlberg T, Rintala EM: Early detection of severe sepsis in the emergency room: diagnostic value of plasma C-reactive protein, procalcitonin, and interleukin-6. Scand J Infect Dis 2011, 43(11–12):883-890.
• [17]Meynaar IA, Droog W, Batstra M, Vreede R, Herbrink P: In Critically Ill Patients, Serum Procalcitonin Is More Useful in Differentiating between Sepsis and SIRS than CRP, Il-6, or LBP. Crit Care Res Pract 2011, 2011:594645.
• [18]Goebel PJ, Williams JB, Gerhardt RT: A Pilot Study of the Performance Characteristics of the D-dimer in Presumed Sepsis. West J Emerg Med 2010, 11(2):173-179.
• [19]Jaimes F, De La Rosa G, Morales C, Fortich F, Arango C, Aguirre D, Munoz A: Unfractioned heparin for treatment of sepsis: A randomized clinical trial (The HETRASE Study). Crit Care Med 2009, 37(4):1185-1196.
• [20]De La Rosa GD, Valencia ML, Arango CM, Gomez CI, Garcia A, Ospina S, Osorno S, Henao A, Jaimes FA: Toward an operative diagnosis in sepsis: a latent class approach. BMC Infect Dis 2008, 8:18. BioMed Central Full Text
• [21]Gamez-Diaz LY, Enriquez LE, Matute JD, Velasquez S, Gomez ID, Toro F, Ospina S, Bedoya V, Arango CM, Valencia ML, et al.: Diagnostic accuracy of HMGB-1, sTREM-1, and CD64 as markers of sepsis in patients recently admitted to the emergency department. Acad Emerg Med 2011, 18(8):807-815.
• [22]Levy MM, Fink MP, Marshall JC, Abraham E, Angus D, Cook D, Cohen J, Opal SM, Vincent JL, Ramsay G, et al.: 2001 SCCM/ESICM/ACCP/ATS/SIS International Sepsis Definitions Conference. Crit Care Med 2003, 31(4):1250-1256.
• [23]Vincent JL, Moreno R, Takala J, Willatts S, De Mendonca A, Bruining H, Reinhart CK, Suter PM, Thijs LG: The SOFA (Sepsis-related Organ Failure Assessment) score to describe organ dysfunction/failure. On behalf of the Working Group on Sepsis-Related Problems of the European Society of Intensive Care Medicine. Intensive Care Med 1996, 22(7):707-710.
• [24]Knaus WA, Draper EA, Wagner DP, Zimmerman JE: APACHE II: a severity of disease classification system. Crit Care Med 1985, 13(10):818-829.
• [25]Garner JS, Jarvis WR, Emori TG, Horan TC, Hughes JM: CDC definitions for nosocomial infections, 1988. Am J Infect Control 1988, 16(3):128-140.
• [26]Buderer NM: Statistical methodology: I. Incorporating the prevalence of disease into the sample size calculation for sensitivity and specificity. Acad Emerg Med 1996, 3(9):895-900.
• [27]Hanley JA, McNeil BJ: The meaning and use of the area under a receiver operating characteristic (ROC) curve. Radiology 1982, 143(1):29-36.
• [28]Lever A, Mackenzie I: Sepsis: definition, epidemiology, and diagnosis. BMJ 2007, 335(7625):879-883.
• [29]Reinhart K, Meisner M, Brunkhorst FM: Markers for sepsis diagnosis: what is useful? Crit Care Clin 2006, 22(3):503-519. ix-x
• [30]Jaimes F, De la Rosa G, Arango C, Fortich F, Morales C, Aguirre D, Patino P: A randomized clinical trial of unfractioned heparin for treatment of sepsis (the HETRASE study): design and rationale [NCT00100308]. Trials 2006, 7:19. BioMed Central Full Text
• [31]Kountchev J, Bijuklic K, Bellmann R, Wiedermann CJ, Joannidis M: Reduction of D-dimer levels after therapeutic administration of antithrombin in acquired antithrombin deficiency of severe sepsis. Crit Care 2005, 9(6):R596-R600. BioMed Central Full Text
• [32]van der Poll T, Levi M: Crosstalk between Inflammation and Coagulation: The Lessons of Sepsis. Curr Vasc Pharmacol 2012, 10(5):632-638.
• [33]Hausfater P, Juillien G, Madonna-Py B, Haroche J, Bernard M, Riou B: Serum procalcitonin measurement as diagnostic and prognostic marker in febrile adult patients presenting to the emergency department. Crit Care 2007, 11(3):R60. BioMed Central Full Text
• [34]Moretti D, Ramirez MM, Settecase CJ, Bagilet DH, Quaglino MB: Usefulness of procalcitonin upon admission to intensive care in the diagnosis and prognosis of sepsis. Med Intensiva 2012, 37(3):156-162.
• [35]Riedel S, Melendez JH, An AT, Rosenbaum JE, Zenilman JM: Procalcitonin as a marker for the detection of bacteremia and sepsis in the emergency department. Am J Clin Pathol 2011, 135(2):182-189.
• [36]Wacker C, Prkno A, Brunkhorst FM, Schlattmann P: Procalcitonin as a diagnostic marker for sepsis: a systematic review and meta-analysis. Lancet Infect Dis 2013, 13(5):426-435.
• [37]Molina FJ, Diaz CA, Barrera L, De La Rosa G, Dennis R, Duenas C, Granados M, Londono D, Ortiz G, Rodriguez F, et al.: Microbiological profile of infections in the Intensive Care Units of Colombia (EPISEPSIS Colombia. Med Intensiva 2011, 35(2):75-83.